Thalia Therapeutics Plc (AIM: THAT)
Health Care · Pharmaceuticals · GB
£0.01
-0.80% today · +4.2% 1Y
Thalia Therapeutics Plc (AIM: THAT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.69M.
Over the last twelve months the share price has gained 4.2%, trading between 0.00 and 0.01.
Tweenvest scores Thalia Therapeutics Plc across four factors: quality 38/100, value 61/100. Its strongest factor is value.
THAT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.69M
- Revenue (TTM)
- $9.57K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.71
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.78B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Union Korea Pharm Co., Ltd.KOSDAQ: A080720 | $14.59M | ₩— | — |
Figures last refreshed Oct 11, 2026.